|Home » Video » Nông Nghiệp Công Nghệ Cao » Nông nghiệp thế giới||[ Add video ]|
Biotech Tobacco Producing Vaccine for Non-Hodgkin Lymphoma
Proteins from a patient's Non-Hodgkin's Lymphoma (NHL) are multiplied in tobacco, purified, and then reintroduced back into the patient, with the expectation the body will produce an immune response. This was a clinical trial in 2001, and produced positive results. A number of patients went into remission. This type of therapy may one day replace chemotherapy.